GRANULOMATOSIS WITH POLYANGIITIS
Clinical trials for GRANULOMATOSIS WITH POLYANGIITIS explained in plain language.
Never miss a new study
Get alerted when new GRANULOMATOSIS WITH POLYANGIITIS trials appear
Sign up with your email to follow new studies for GRANULOMATOSIS WITH POLYANGIITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Study tests cheaper copycat drug for serious autoimmune disease
Disease control CompletedThis study aimed to see if newer, more affordable 'biosimilar' versions of the drug rituximab work as well and are as safe as the original version for patients with two serious autoimmune diseases (GPA and MPA). Researchers followed 201 Canadian patients for two years, tracking t…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Trial tests if patients can stop steroids for good
Disease control CompletedThis study aimed to find the best way to keep a rare autoimmune disease called granulomatosis with polyangiitis (GPA) in remission. It compared whether patients could safely stop taking the steroid prednisone entirely or if they needed to stay on a very low daily dose to prevent …
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE3 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Smart dosing vs. scheduled shots: a fight to keep a serious autoimmune disease at bay
Disease control CompletedThis study tested two different long-term treatment plans for patients with a serious autoimmune disease called ANCA-associated vasculitis, who were already in remission. The goal was to see which plan was better at preventing the disease from flaring up again. One plan gave ritu…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Common drug tested for hidden power against debilitating autoimmune symptoms
Symptom relief CompletedThis study tested whether a very low dose of an existing medication (naltrexone) could improve daily life for people with several types of vasculitis, a group of autoimmune diseases that cause blood vessel inflammation. The trial involved 60 adults whose disease was stable but wh…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
Scientists probe blood cells for clues to tame rare disease
Knowledge-focused CompletedThis study aimed to understand how a specific type of white blood cell, called a neutrophil, behaves in people with granulomatosis with polyangiitis (GPA), a rare autoimmune disease. Researchers studied blood samples from 93 patients to see if changes in these cells could serve a…
Matched conditions: GRANULOMATOSIS WITH POLYANGIITIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC